CRI Liver Cancer Immunotherapy Clinical Trial Finder

Liver cancer needs new, more effective treatments to help the approximately 42,000 people in the United States who are diagnosed each year. The most common form of liver cancer is hepatocellular carcinoma (HCC), which may be caused by the hepatitis virus, cirrhosis, obesity, or diabetes.

Clinical trials offer cutting-edge therapies to patients with liver cancer, including cancer immunotherapy, which harnesses and enhances the innate powers of the immune system to fight cancerous tumors.

The Cancer Research Institute has partnered with EmergingMed to provide the Liver Cancer Immunotherapy Clinical Trial Finder. Call now or fill out the form on the right to identify immunotherapy clinical trials that match your specific diagnosis, treatment history, and genomic profile. The service is completely free and confidential to patients

Call Now

Monday - Friday: 8:00 am - 6:00 pm ET

Se Habla Español
1-866-914-7350
(local) 646-625-7323

Request an Email or Phone Call

Do we have permission to call you to review your matches, provide detailed contact information, and update your profile?

By registering with EmergingMed or participating in the clinical trial matching and referral process, I acknowledge that I am 18 years of age or older. I understand that a health care professional should be consulted to discuss clinical trial information because this service is not a substitute for medical advice and further information will be needed to determine eligibility for a clinical trial.

I agree that I have read, understand, and accept the Terms & Conditions and further, that I have read, understand, and accept the Privacy Policy.

This service is sponsored by